• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Ekladious, L. (2021). THE ROLE OF DIFFUSION WEIGHTED IMAGING IN DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN LESIONS. ALEXMED ePosters, 3(3), 4-5. doi: 10.21608/alexpo.2021.78408.1169
Liza Shehata Ekladious. "THE ROLE OF DIFFUSION WEIGHTED IMAGING IN DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN LESIONS". ALEXMED ePosters, 3, 3, 2021, 4-5. doi: 10.21608/alexpo.2021.78408.1169
Ekladious, L. (2021). 'THE ROLE OF DIFFUSION WEIGHTED IMAGING IN DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN LESIONS', ALEXMED ePosters, 3(3), pp. 4-5. doi: 10.21608/alexpo.2021.78408.1169
Ekladious, L. THE ROLE OF DIFFUSION WEIGHTED IMAGING IN DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN LESIONS. ALEXMED ePosters, 2021; 3(3): 4-5. doi: 10.21608/alexpo.2021.78408.1169

THE ROLE OF DIFFUSION WEIGHTED IMAGING IN DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN LESIONS

Article 149, Volume 3, Issue 3, September 2021, Page 4-5  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.78408.1169
View on SCiNiTO View on SCiNiTO
Author
Liza Shehata Ekladious email
Department of Radiodiagnosis, Faculty of Medicine, Alexandria University, Egypt
Abstract
• Ovarian carcinomas represent 6th most common cancer, the second most common gynecologic cancer and 4th leading cause of cancer death in women. With no viable screening estimates accessible, 70% of ovarian malignancies are diagnosed at a late stage. Separation of benign lesions from the malignant ones is of foremost significance to direct the correct clinical management. Imaging modalities, particularly ultrasonography (US), computed tomography (CT), and magnetic resonance (MR) imaging have become the first line for ovarian lesions diagnosis.
• US remains the study of choice in the initial evaluation of suspected adnexal masses because it is relatively inexpensive, noninvasive, and widely available. Transabdominal US, endovaginal US, or both should be performed for the evaluation of adnexal masses.
• MR imaging is a useful modality for differentiating benign and malignant ovarian tumors, and a specific diagnosis can be made for certain pathologic entities. Morphologic appearance, signal intensity characteristics, DWI and adequate use of intravenous contrast material provide information for arriving at the correct diagnosis.
Keywords
DWI; OVARIAN LESIONS; BENIGN AND MALIGNANT
Supplementary Files
download 0004-1169 Warda_s-Poster.pdf
Statistics
Article View: 204
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.